Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PEPG

PepGen (PEPG)

PepGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PEPG
DateTimeSourceHeadlineSymbolCompany
25/02/202508:14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PEPGPepGen Inc
24/02/202523:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PEPGPepGen Inc
24/02/202523:30Business WirePepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate HighlightsNASDAQ:PEPGPepGen Inc
24/02/202523:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PEPGPepGen Inc
24/02/202523:00Business WirePepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1NASDAQ:PEPGPepGen Inc
30/01/202508:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PEPGPepGen Inc
30/01/202508:05Business WirePepGen Announces CONNECT Program UpdatesNASDAQ:PEPGPepGen Inc
17/12/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PEPGPepGen Inc
17/12/202400:00Business WirePepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular DystrophyNASDAQ:PEPGPepGen Inc
22/11/202408:05Business WirePepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical DevelopmentNASDAQ:PEPGPepGen Inc
08/11/202400:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PEPGPepGen Inc
08/11/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PEPGPepGen Inc
08/11/202400:00Business WirePepGen Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:PEPGPepGen Inc
05/11/202400:00Business WirePepGen to Participate in Upcoming Investor ConferencesNASDAQ:PEPGPepGen Inc
08/10/202423:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PEPGPepGen Inc
08/10/202422:00Business WirePepGen Announces Presentations at the 29th Annual Congress of the World Muscle SocietyNASDAQ:PEPGPepGen Inc
20/09/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PEPGPepGen Inc
20/09/202406:30Business WirePepGen Announces Christopher Ashton, PhD, to Retire from its Board of DirectorsNASDAQ:PEPGPepGen Inc
21/08/202406:05Business WirePepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & DevelopmentNASDAQ:PEPGPepGen Inc
20/08/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PEPGPepGen Inc
20/08/202422:00Business WirePepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & DevelopmentNASDAQ:PEPGPepGen Inc
08/08/202422:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PEPGPepGen Inc
08/08/202422:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PEPGPepGen Inc
08/08/202422:00Business WirePepGen Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:PEPGPepGen Inc
31/07/202406:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PEPGPepGen Inc
31/07/202406:02Business WirePepGen Announces Positive Data from Low-Dose Cohort of PGN-EDO51 in Ongoing CONNECT1-EDO51 Phase 2 Clinical Trial for Treatment of Duchenne Muscular DystrophyNASDAQ:PEPGPepGen Inc
27/07/202406:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PEPGPepGen Inc
20/07/202406:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PEPGPepGen Inc
17/07/202406:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PEPGPepGen Inc
09/07/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PEPGPepGen Inc
 Showing the most relevant articles for your search:NASDAQ:PEPG